NANOS 2026 Annual Meeting (North American Neuro-Ophthalmology Society) (Videos)

Neuro-Ophthalmology • Clinical Imaging • AI • Optic Nerve Disease • Eye Movement Disorders

March 20–24, 2026 | Boston, Massachusetts

Stay current with rapidly evolving advances in neuro-ophthalmology with the NANOS 2026 Annual Meeting (North American Neuro-Ophthalmology Society) (Videos).

The 52nd Annual Meeting of the North American Neuro-Ophthalmology Society (NANOS) was held March 20–24, 2026, at the Boston Marriott Copley Place in Boston, Massachusetts. The scientific program brought together clinicians, researchers, fellows, residents, and educators for multidisciplinary education focused on complex neuro-ophthalmic disease, diagnostic reasoning, imaging, emerging evidence, rare clinical cases, and new technologies.

Neuro-ophthalmology continues to evolve through new diagnostic frameworks, emerging treatment evidence, advanced imaging, and artificial intelligence-driven clinical tools. NANOS 2026 addressed these changes through scientific platforms, case-based sessions, symposia, lectures, workshops, and the traditional Frank B. Walsh Symposium.

The meeting was designed to help clinicians translate new research and diagnostic strategies into real-world decision-making across ophthalmology and neurology.

Course Details

• Product: NANOS 2026 Annual Meeting
• Organization: North American Neuro-Ophthalmology Society – NANOS
• Meeting: 52nd Annual Meeting
• Year: 2026
• Meeting Dates: March 20–24, 2026
• Venue: Boston Marriott Copley Place
• Location: Boston, Massachusetts, USA
• Product Format: Videos
• Primary Specialty: Neuro-Ophthalmology
• Related Specialties: Ophthalmology, Neurology
• Primary Focus: Contemporary Neuro-Ophthalmic Diagnosis, Management, Imaging, Research, and Clinical Decision-Making
• Educational Formats: Scientific Sessions, Walsh Symposium, Symposia, Lectures, Workshops, Case-Based Education, Scientific Platforms
• Official On-Demand Availability: 2026 post-meeting educational content

The official NANOS On-Demand program provides access to the meeting’s complete educational content organized sequentially or by individual session.

Who Was the Original Program Designed For?

NANOS 2026 is particularly relevant for professionals involved in the diagnosis and management of neuro-ophthalmic disease, including:

• Neuro-Ophthalmologists
• Ophthalmologists
• Neurologists
• Neuro-Ophthalmology Fellows
• Ophthalmology Residents
• Neurology Residents
• Researchers
• Clinician-Scientists
• Fellows-in-Training
• Allied Health Professionals working in neuro-ophthalmic care

NANOS describes its Annual Meeting community as including clinicians, scientists, trainees, and other professionals involved in advancing neuro-ophthalmology.

Educational Focus

The 2026 program combined cutting-edge research, case-based education, practical skill development, and multidisciplinary discussion.

Major educational areas included:

• Complex neuro-ophthalmic diagnosis
• Optic neuropathies
• Neuro-imaging
• Ophthalmic imaging
• Optical coherence tomography
• Eye movement disorders
• Diplopia
• Strabismus
• Thyroid eye disease
• Idiopathic intracranial hypertension
• Central retinal artery occlusion
• NAION
• Optic neuritis
• NMOSD
• MOGAD
• Myasthenia gravis
• Neuro-infectious diseases
• Neurovascular disease
• Mitochondrial disease
• Pediatric neuro-ophthalmology
• Rare neuro-ophthalmic conditions
• Artificial intelligence
• Clinical research
• Scientific case presentations

Frank B. Walsh Symposium

A major component of the NANOS Annual Meeting is the Frank B. Walsh Symposium, one of the specialty’s established forums for challenging and educational neuro-ophthalmology cases.

The 58th Frank B. Walsh Symposium formed a major part of the Saturday program at NANOS 2026 and featured unusual, complex, and diagnostically challenging cases.

These sessions support learning through:

Clinical Presentation → Differential Diagnosis → Imaging → Diagnostic Reasoning → Final Diagnosis

Complex & Rare Neuro-Ophthalmology Cases

Rare and diagnostically challenging cases remain central to neuro-ophthalmology education.

The NANOS 2026 program highlighted unusual presentations where interpretation of:

• History
• Neuro-ophthalmic examination
• Imaging
• Visual fields
• OCT
• Laboratory findings
• Neurologic features

can be critical to establishing an accurate diagnosis.

One official On-Demand preview, When the Retina Spoke Up, demonstrates the meeting’s emphasis on diagnostically challenging cases.

Neuro-Ophthalmology Imaging

Modern neuro-ophthalmology relies heavily on the integration of clinical examination with ophthalmic and neurologic imaging.

NANOS 2026 addressed imaging in the context of:

• Diagnostic reasoning
• OCT
• Ophthalmic imaging
• Neurovascular disease
• Optic nerve disease
• Eye movement abnormalities
• Artificial intelligence

The program emphasized using imaging as part of broader clinical interpretation rather than as an isolated diagnostic tool.

Optical Coherence Tomography – OCT

OCT was represented among the member-developed educational workshops and neuro-ophthalmic imaging topics.

Its role in neuro-ophthalmology includes evaluating structural changes affecting:

• Optic nerve
• Retinal nerve fiber layer
• Ganglion cells
• Neuro-ophthalmic disease progression

NANOS 2026 included dedicated workshop content involving OCT.

Artificial Intelligence in Neuro-Ophthalmology

One of the major future-focused themes of NANOS 2026 was artificial intelligence.

The closing-day session:

Neuro-Ophthalmology in the Age of AI: Insights, Innovations, and Implementation

focused on emerging AI applications involving:

• Clinical imaging
• Diagnostics
• Clinical workflows
• Education
• Decision support
• Implementation
• Ethics
• Regulation
• Future innovation

The official NANOS program specifically identified AI in imaging, education, and clinical workflows as major areas of discussion.

AI in Ophthalmic Imaging

The official NANOS On-Demand preview includes:

Getting Ophthalmic Imaging AI in the Clinic

This session examines how artificial intelligence is influencing:

• Imaging interpretation
• Diagnostic workflows
• Clinical reasoning
• Practical implementation

and demonstrates the growing role of AI in neuro-ophthalmology practice.

NAION

Non-Arteritic Anterior Ischemic Optic Neuropathy – NAION received a dedicated major session:

New Eyes on NAION: Revisiting Risk in a Changing Medical Landscape

The session addressed changing concepts surrounding:

• Systemic risk
• Anatomical risk
• Iatrogenic considerations
• Contemporary medical factors
• Emerging evidence
• Clinical decision-making

The official program also highlighted discussion of GLP-1-related insights and actionable clinical strategies.

Optic Nerve Disorders

Optic nerve disease represents a core component of neuro-ophthalmology.

The broader NANOS 2026 program included topics related to:

• NAION
• Optic neuritis
• MOGAD
• NMOSD
• Neuro-inflammatory disease
• Ischemic optic neuropathy
• Imaging and diagnostic assessment

Poster and scientific content also highlighted several of these disorders.

NMOSD & MOGAD

Neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody-associated disease (MOGAD) were represented among the highlighted scientific and poster topics.

These conditions are increasingly important in the differential diagnosis of inflammatory optic neuropathy.

Idiopathic Intracranial Hypertension – IIH

NANOS 2026 included contemporary evidence related to idiopathic intracranial hypertension (IIH).

The session:

Eyes on the Evidence: What’s New in Treating Neuro-Ophthalmic Disease?

included IIH among its major evidence-focused disease areas.

Central Retinal Artery Occlusion – CRAO

Central retinal artery occlusion (CRAO) was another important component of the evidence-based treatment update.

The program examined current therapeutic evidence and evolving clinical management within neuro-ophthalmology.

Thyroid Eye Disease – TED

Thyroid eye disease (TED) featured prominently in the 2026 educational program.

Topics included:

• Active versus chronic TED
• Diagnostic criteria
• Clinical tools
• Individualized treatment planning
• Current therapeutic evidence
• Investigational therapies
• Quality of life

The program included education addressing how newer treatments may influence contemporary TED management.

Neuro-Infectious Disease

The program included the dedicated session:

Bugs, Brains, and Blindness

focused on neuro-infectious conditions relevant to neuro-ophthalmology.

This reflects the intersection between:

Infectious Disease → Neurology → Ophthalmology → Neuro-Ophthalmic Manifestations

The session was one of the highlighted Sunday educational programs.

Pediatric Neuro-Ophthalmology

NANOS 2026 included collaboration with pediatric ophthalmology through joint educational sessions.

One featured session was:

Small Patients, Big Mysteries: Diagnostic & Management Dilemmas that Test the Experts of AAPOS & NANOS

The meeting also included a joint strabismus case symposium involving AAPOS and NANOS experts.

Strabismus & Diplopia

Eye alignment and movement disorders remain important areas of neuro-ophthalmic practice.

The program included:

• Strabismus cases
• Diplopia
• Eye movement assessment
• Efferent disorders
• Systematic evaluation of ocular motility

These areas were addressed through joint symposia, bootcamp education, and scientific presentations.

Neuro-Ophthalmology Bootcamp

The session:

Neuro-Ophthalmology Bootcamp: Vision, Movement, and the Unexpected

was designed as a trainee-focused, interactive clinical education experience.

The official program described learning goals involving:

• Recognizing conditions that produce neuro-ophthalmic symptoms
• Systematic eye-movement examination
• Interpretation of OCT
• Interpretation of visual fields

Emerging Neuro-Ophthalmic Conditions

The session:

Recently Recognized, Clinically Relevant: New Conditions Every Neuro-Ophthalmologist Should Know

focused on newly recognized or increasingly important conditions.

Areas included:

• Genetic disease
• Relapsing autoimmune conditions
• Eye movement abnormalities associated with genetic disease
• Neuro-ophthalmic complications of cancer treatments
• Autoimmune nodopathies

The goal was to help clinicians integrate newer disease concepts into practical neuro-ophthalmic care.

Neuro-Ophthalmology & Cancer Therapy

Modern oncology treatments can produce important neurologic and ophthalmic adverse effects.

NANOS 2026 addressed neuro-ophthalmic complications of cancer treatments, including their recognition and potential implications for the patient’s overall treatment plan.

Autoimmune Nodopathies

Autoimmune nodopathies were included among the emerging conditions reviewed during the meeting.

The educational program addressed recognition of their neuro-ophthalmic manifestations and appropriate diagnostic evaluation.

Neurovascular Neuro-Ophthalmology

Member-developed educational content included neurovascular topics, supporting the evaluation of conditions at the intersection of cerebrovascular disease and visual pathways.

This area connects:

Neurology + Vascular Disease + Vision + Neuro-Ophthalmic Examination

Mitochondrial Disease

Mitochondrial disorders were included among the member-developed educational workshop themes at the meeting.

These diseases can produce complex optic nerve, neurologic, and systemic manifestations requiring multidisciplinary assessment.

Scientific Platforms

NANOS 2026 included multiple Scientific Platform sessions presenting contemporary research in neuro-ophthalmology.

These sessions provide opportunities to review:

• Emerging research
• Clinical studies
• New diagnostic concepts
• Treatment evidence
• Neuro-ophthalmic outcomes
• Translational science

Scientific Platforms I and II were both included in the official program.

Major Topics Covered

• Neuro-Ophthalmology
• NANOS 2026
• Optic Neuropathy
• Neuro-Ophthalmic Imaging
• Ophthalmic Imaging
• Optical Coherence Tomography
• OCT
• Visual Fields
• Diagnostic Reasoning
• Frank B. Walsh Symposium
• Rare Neuro-Ophthalmology Cases
• Eye Movement Disorders
• Diplopia
• Strabismus
• Efferent Disorders
• NAION
• Optic Neuritis
• NMOSD
• MOGAD
• Idiopathic Intracranial Hypertension
• IIH
• Central Retinal Artery Occlusion
• CRAO
• Thyroid Eye Disease
• TED
• Myasthenia Gravis
• Neuro-Infectious Disease
• Pediatric Neuro-Ophthalmology
• Neurovascular Disease
• Mitochondrial Disorders
• Genetic Neuro-Ophthalmic Disease
• Autoimmune Nodopathies
• Cancer Treatment Complications
• Artificial Intelligence
• AI in Ophthalmology
• AI in Medical Imaging
• Clinical Decision Support
• Scientific Research
• Case-Based Learning
• Neuro-Ophthalmology Education

Who Should Take This Course?

The NANOS 2026 Annual Meeting (Videos) is particularly relevant for:

• Neuro-Ophthalmologists
• Ophthalmologists
• Neurologists
• Neuro-Ophthalmology Fellows
• Ophthalmology Residents
• Neurology Residents
• Optic Nerve Specialists
• Clinicians managing complex visual disorders
• Researchers in neuro-ophthalmology
• Clinician-Scientists
• Medical professionals interested in neuro-imaging and AI
• Healthcare professionals involved in multidisciplinary neuro-ophthalmic care

The strongest clinical audience remains:

Neuro-Ophthalmology + Ophthalmology + Neurology

Why This Course Is Useful

NANOS 2026 Annual Meeting provides a broad review of contemporary neuro-ophthalmology combining challenging cases, evidence-based treatment updates, imaging, research, emerging disease entities, and new technologies.

The program connects several major areas:

Optic Nerve Disease

• NAION
• Optic neuritis
• NMOSD
• MOGAD

Intracranial & Vascular Disease

• IIH
• CRAO
• Neurovascular conditions

Orbital & Autoimmune Disease

• Thyroid eye disease
• Autoimmune nodopathies

Eye Movement & Alignment

• Diplopia
• Strabismus
• Efferent disorders
• Eye movement evaluation

Imaging & Diagnostics

• OCT
• Visual fields
• Neuro-imaging
• Ophthalmic imaging

Emerging Practice

• Artificial intelligence
• AI-driven imaging
• Genetic disease
• Cancer treatment complications
• New clinical entities

Scientific Education

• Walsh cases
• Scientific platforms
• Symposia
• Clinical workshops
• Evidence updates

The overall clinical pathway can be summarized as:

Symptoms → Examination → Imaging → Differential Diagnosis → Evidence → Management

Original NANOS CME Information

The official NANOS 2026 On-Demand educational activity is listed by NANOS as offering up to 29.5 AMA PRA Category 1 Credits™ through the official NANOS/MER educational platform. The live meeting was designated for up to 25 credits.

These credits apply to eligible participation through the official NANOS educational activity and completion of the provider’s requirements.

An independently distributed MedicalAmboss video package should not automatically be represented as providing:

• NANOS CME credit
• AMA PRA Category 1 Credits™
• Official NANOS certificate
• Official NANOS account access
• Official On-Demand platform access
• Official syllabus access

unless these are specifically included with the purchase.

Product Summary

• Product: NANOS 2026 Annual Meeting (North American Neuro-Ophthalmology Society) (Videos)
• Organization: North American Neuro-Ophthalmology Society – NANOS
• Meeting: 52nd Annual Meeting
• Year: 2026
• Dates: March 20–24, 2026
• Venue: Boston Marriott Copley Place
• Location: Boston, Massachusetts
• Format: Videos
• Primary Specialty: Neuro-Ophthalmology
• Related Specialties: Ophthalmology, Neurology
• Major Areas: Optic Neuropathy, Imaging, Eye Movement Disorders, TED, IIH, NAION, CRAO, Neuro-Infectious Disease, AI
• Primary Audience: Neuro-Ophthalmologists, Ophthalmologists, Neurologists, Fellows, Residents, and Researchers

Short Description

NANOS 2026 Annual Meeting (North American Neuro-Ophthalmology Society) (Videos) provides comprehensive education from the 52nd NANOS Annual Meeting held March 20–24, 2026, in Boston, Massachusetts.

The program covers NAION, IIH, CRAO, thyroid eye disease, optic neuritis, NMOSD, MOGAD, eye movement disorders, OCT, visual fields, neuro-infectious disease, pediatric neuro-ophthalmology, emerging neuro-ophthalmic conditions, scientific research, rare Walsh cases, and artificial intelligence in imaging and clinical practice.

Topics

Major confirmed educational sessions and program areas include:

• 58th Frank B. Walsh Symposium
• Small Patients, Big Mysteries: Diagnostic & Management Dilemmas that Test the Experts of AAPOS & NANOS
• Two Eyes, Two Images, Two Subspecialties: A Strabismus Case Symposium Featuring Experts from AAPOS and NANOS
• Bugs, Brains, and Blindness
• Neuro-Ophthalmology Bootcamp: Vision, Movement, and the Unexpected
• Recently Recognized, Clinically Relevant: New Conditions Every Neuro-Ophthalmologist Should Know
• Scientific Platforms I
• Scientific Platforms II
• Jacobson Lecture
• Eyes on the Evidence: What’s New in Treating Neuro-Ophthalmic Disease?
• New Eyes on NAION: Revisiting Risk in a Changing Medical Landscape
• Neuro-Ophthalmology in the Age of AI: Insights, Innovations, and Implementation
• OCT Workshops
• Neurovascular Topics
• Mitochondrial Disorders
• Thyroid Eye Disease
• CRAO
• IIH
• NAION
• Optic Neuritis
• NMOSD
• MOGAD
• Myasthenia Gravis
• Diplopia
• Efferent Disorders
• Artificial Intelligence in Neuro-Ophthalmology
• AI in Ophthalmic Imaging
• Neuro-Infectious Disease
• Genetic Neuro-Ophthalmic Conditions
• Neuro-Ophthalmic Complications of Cancer Treatment
• Autoimmune Nodopathies